These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33116620)

  • 21. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
    Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
    BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma.
    Li J; Wang X; Tang J; Jiang R; Zhang W; Ji J; Sun B
    Cell Physiol Biochem; 2015; 37(2):687-96. PubMed ID: 26356260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma.
    Li W; Chen QF; Huang T; Wu P; Shen L; Huang ZL
    Front Oncol; 2020; 10():780. PubMed ID: 32587825
    [No Abstract]   [Full Text] [Related]  

  • 24. Identification of aberrantly expressed lncRNA and the associated TF-mRNA network in hepatocellular carcinoma.
    Wang B; Tang D; Zhang Z; Wang Z
    J Cell Biochem; 2020 Feb; 121(2):1491-1503. PubMed ID: 31498488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long noncoding RNA AWPPH promotes hepatocellular carcinoma progression through YBX1 and serves as a prognostic biomarker.
    Zhao X; Liu Y; Yu S
    Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1805-1816. PubMed ID: 28428004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of long non-coding RNAs to reveal potential prognostic biomarkers in hepatocellular carcinoma.
    Ma Y; Luo T; Dong D; Wu X; Wang Y
    Gene; 2018 Jul; 663():148-156. PubMed ID: 29684484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of long non‑coding RNA‑messenger RNA‑microRNA co‑expression network identifies cell cycle‑related lncRNA in hepatocellular carcinoma.
    Zhu HR; Yu XN; Zhang GC; Shi X; Bilegsaikhan E; Guo HY; Liu LL; Cai Y; Song GQ; Liu TT; Dong L; Janssen HLA; Weng SQ; Wu J; Shen XZ; Zhu JM
    Int J Mol Med; 2019 Nov; 44(5):1844-1854. PubMed ID: 31485608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
    Lu J; Li B; Xiong X; Cheng N
    Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma.
    Hua L; Wang CY; Yao KH; Chen JT; Zhang JJ; Ma WL
    Int J Clin Exp Pathol; 2015; 8(3):3076-82. PubMed ID: 26045820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray.
    Liu WT; Lu X; Tang GH; Ren JJ; Liao WJ; Ge PL; Huang JF
    World J Gastroenterol; 2014 May; 20(20):6314-21. PubMed ID: 24876753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage-associated lncRNA ELMO1-AS1: a novel therapeutic target and prognostic biomarker for hepatocellular carcinoma.
    Luo T; Chen M; Zhao Y; Wang D; Liu J; Chen J; Luo H; Li L
    Onco Targets Ther; 2019; 12():6203-6216. PubMed ID: 31498334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long non‑coding RNA‑based risk scoring system predicts prognosis of alcohol‑related hepatocellular carcinoma.
    Luo Y; Ye J; Wei J; Zhang J; Li Y
    Mol Med Rep; 2020 Aug; 22(2):997-1007. PubMed ID: 32468063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long non-coding RNA LINC00152 is up-regulated in ovarian cancer tissues and regulates proliferation and cell cycle of SKOV3 cells.
    Ni H; Niu LL; Tian SC; Jing LK; Zhang LT; Lin QQ; Cai YH; Liang HM; Du Q; Li H
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9803-9813. PubMed ID: 31799647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long non-coding RNA LINC01503 promotes the progression of hepatocellular carcinoma via activating MAPK/ERK pathway.
    Wang MR; Fang D; Di MP; Guan JL; Wang G; Liu L; Sheng JQ; Tian DA; Li PY
    Int J Med Sci; 2020; 17(9):1224-1234. PubMed ID: 32547318
    [No Abstract]   [Full Text] [Related]  

  • 36. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
    Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New LncRNAs in Chronic Hepatitis C progression: from fibrosis to hepatocellular carcinoma.
    Ferrasi AC; Fernandez GJ; Grotto RMT; Silva GF; Goncalves J; Costa MC; Enguita FJ; Pardini MIMC
    Sci Rep; 2020 Jun; 10(1):9886. PubMed ID: 32555359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Construction of a Ferroptosis-Related Nine-lncRNA Signature for Predicting Prognosis and Immune Response in Hepatocellular Carcinoma.
    Xu Z; Peng B; Liang Q; Chen X; Cai Y; Zeng S; Gao K; Wang X; Yi Q; Gong Z; Yan Y
    Front Immunol; 2021; 12():719175. PubMed ID: 34603293
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression and Clinical Significance of the Novel Long Noncoding RNA ZNF674-AS1 in Human Hepatocellular Carcinoma.
    Zhang L; He T; Yan Y; Zhang Y; Zhou X; Huang P; Kong Y; Xie M; Zhang L; Sun Q; Zhou D; Xie H; Zhou L; Zheng S; Wang W
    Biomed Res Int; 2016; 2016():3608914. PubMed ID: 27896271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.